The FTC is attacking drugmakers’ ‘patent thickets’

The Federal Trade Commission has challenged the validity of over 100 drug product patents, focusing on devices used to deliver medicines, like inhalers and autoinjectors, in an effort to increase competition and potentially lower some prices.

Wesana Health Announces Closing of Previously Announced SANA-013 Asset Sale – Psychedelic Alpha

CHICAGO and TORONTO, July 05, 2023 (GLOBE NEWSWIRE) — Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE:WESA; OTCQB:WSNAF), today announced the successful closing of the

July 5, 2023

Editorial: Trump & Harris want weed legalized, ignore downside – The Cannabist

Legalizing marijuana isn’t as hot-button an issue in this election as abortion or immigration, but both presidential candidates former President Donald Trump and Vice President

October 2, 2024

Reunion Neuroscience Inc. Announces $103 Million Series A Financing Co-Led by MPM BioImpact and Novo Holdings | Psychedelic Invest

MORRISTOWN, N.J., May 02, 2024 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to pushing the boundaries of neuroscience, today announced the

May 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.